Resolute Wealth Strategies’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Resolute Wealth Strategies’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$220K	Buy	+889	New	+$191K	0.09%	117
2025 Q2	–	Sell	-1,327	Closed	-$226K	–	103
2025 Q1	$226K	Hold	1,327	–	–	0.13%	94
2024 Q4	$221K	Sell	1,327 -18	-1%	-$3.08K	0.11%	89
2024 Q3	$231K	Sell	1,345 -75	-5%	-$12.4K	0.12%	89
2024 Q2	$219K	Sell	1,420 -140	-9%	-$21K	0.13%	87
2024 Q1	$240K	Hold	1,560	–	–	0.15%	84
2023 Q4	$247K	Sell	1,560 -103	-6%	-$14.8K	0.17%	79
2023 Q3	$243K	Sell	1,663 -10	-0.6%	-$1.52K	0.18%	73
2023 Q2	$256K	Hold	1,673	–	–	0.2%	74
2023 Q1	$259K	Buy	+1,673	New	+$263K	0.22%	71

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Resolute Wealth Strategies's FBT Position: Q2 2026 in Review

Resolute Wealth Strategies opened a new position in First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2026: 889 shares worth $220K. The stake represents 0.09% of the portfolio and ranks #117 among its holdings. This is a return to the name: Resolute Wealth Strategies previously reported a position in FBT as recently as Q1 2025.

Resolute Wealth Strategies first reported a position in FBT in Q1 2023 and has held it in 10 quarters since. The position peaked at $259K in Q1 2023. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

Resolute Wealth Strategies held 889 shares of First Trust NYSE Arca Biotechnology Index Fund worth $220K as of Q2 2026.
First Trust NYSE Arca Biotechnology Index Fund was a new Resolute Wealth Strategies position in Q2 2026.
First Trust NYSE Arca Biotechnology Index Fund made up 0.09% of Resolute Wealth Strategies's portfolio in Q2 2026, its #117 holding.
Resolute Wealth Strategies first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2023 and has held it in 10 quarters since.
Resolute Wealth Strategies's First Trust NYSE Arca Biotechnology Index Fund position peaked at $259K in Q1 2023.
339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Resolute Wealth Strategies's 13F filing for Q2 2026, filed 12 Aug 2026.